Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
Title:
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
Author:
Kantarjian, Hagop M Hochhaus, Andreas Saglio, Giuseppe De Souza, Carmino Flinn, Ian W Stenke, Leif Goh, Yeow-Tee Rosti, Gianantonio Nakamae, Hirohisa Gallagher, Neil J Hoenekopp, Albert Blakesley, Rick E Larson, Richard A Hughes, Timothy P